HHS urges Supreme Court to decline AstraZeneca’s petition over Medicare price negotiationsnews2026-01-05T19:42:19+00:00January 5th, 2026|Endpoints News|
Federal judge blocks 340B drug pricing pilot ahead of Jan. 1 effective datenews2025-12-29T21:20:03+00:00December 29th, 2025|Endpoints News|
Bristol Myers brings IRA drug pricing fight to Supreme Courtnews2025-12-22T18:04:49+00:00December 22nd, 2025|Endpoints News|
US charges six people with insider trading in case including Olema Oncologynews2025-12-22T17:43:48+00:00December 22nd, 2025|Endpoints News|
Senators point fingers over who blocked the rare disease voucher reauthorizationnews2025-12-19T15:43:21+00:00December 19th, 2025|Endpoints News|
340B sales grew 23% last year, and court battle over pilot program intensifies news2025-12-12T20:47:51+00:00December 12th, 2025|Endpoints News|
Top Trump lawyer calls on SCOTUS to reverse ‘skinny’ generic drug label decisionnews2025-12-11T19:05:07+00:00December 11th, 2025|Endpoints News|
Apple Tree files for bankruptcy as it seeks funds from Russian billionaire backernews2025-12-10T19:21:12+00:00December 10th, 2025|Endpoints News|
Apple Tree Partners scores legal win against alleged holdout Russian investornews2025-12-06T11:37:53+00:00December 6th, 2025|Endpoints News|
German court stops Merck from selling subcutaneous Keytruda in patent battle with Halozymenews2025-12-05T12:01:34+00:00December 5th, 2025|Endpoints News|
